Jacob Asset Management Of New York LLC Aerie Pharmaceuticals Inc Transaction History

Jacob Asset Management Of New York LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.95 - $9.16 $180,279 - $333,607	-36,420 Reduced 14.77%	210,143 $1.58 Million
Q1 2022 May 12, 2022	BUY	$5.64 - $9.8 $10,039 - $17,444	1,780 Added 0.73%	246,563 $2.24 Million
Q4 2021 Feb 09, 2022	BUY	$7.02 - $13.33 $361,649 - $686,721	51,517 Added 26.66%	244,783 $1.72 Million
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $726,359 - $1.07 Million	64,166 Added 49.7%	193,266 $2.2 Million
Q2 2021 Oct 04, 2021	BUY	$15.16 - $18.97 $697,360 - $872,620	46,000 Added 55.35%	129,100 $2.07 Million
Q1 2021 Oct 04, 2021	BUY	$13.12 - $20.9 $236,160 - $376,200	18,000 Added 27.65%	83,100 $1.49 Million
Q4 2020 Oct 04, 2021	BUY	$9.12 - $14.49 $593,712 - $943,299	65,100 New	65,100 $880,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.